|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
Cambridge Healthtech Institute's Intelligent Drug Discovery and Development 2003 | ||||||||||||||||
January 28, 2003 | ||||||||||||||||
Cambridge Healthtech Institute, Wyndham Franklin Plaza Hotel, 17th and Race Streets, Philadelphia, PA 19103 May 28-30, 2003 New In 2003! Innovative screening approaches Literature data mining Metabolic profiling Novel targets vs. novel chemistry Pre- and post-conference tutorials Presentations from 14 of the top pharmaceutical companies in the world* Pfizer Johnson & Johnson GlaxoSmithKline Novartis Merck Eli Lilly Amgen Pharmacia AstraZeneca Bristol-Myers Squibb Aventis Schering-Plough Hoffmann-La Roche Genentech *MedAdNews, 2002 |
||||||||||||||||
Organized by: | Cambridge Healthtech Institute | |||||||||||||||
Invited Speakers: | Dr. Lee E. Babiss, Vice President of Preclinical R&D Hoffmann-La Roche, Inc Dr. Peter Jurs, Chemistry Department, Penn State University Dr. George Scangos Chief Executive Officer, Exelexis, Inc. Dr. Daniel Shirlin, Head of Global Lead Generation, Aventis DI&A |
|||||||||||||||
Deadline for Abstracts: | April 11, 2003 | |||||||||||||||
Registration: | REGISTER BY FEBRUARY 7 AND SAVE $300!!! Call 617-630-1300 (fax 617-630-1325) and ask for the registration department. or e-mail chi@healthtech.com Also registration is available online | |||||||||||||||
E-mail: | eeskedal@healthtech.com | |||||||||||||||
Posted by: | Elaine Eskedal | |||||||||||||||
Host: | wks152.healthtech.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |